The nuclear factor NF-kappaB pathway in inflammation.

PubWeight™: 4.53‹?› | Rank: Top 1%

🔗 View Article (PMC 2882124)

Published in Cold Spring Harb Perspect Biol on October 07, 2009

Authors

Toby Lawrence1

Author Affiliations

1: Inflammation Biology Group, Centre d'Immunologie Marseille-Luminy, Parc Scientifique de Luminy, Case 906, 13288 Marseille, France. lawrence@ciml.univ-mrs.fr

Articles citing this

(truncated to the top 100)

NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev (2012) 5.77

A molecular web: endoplasmic reticulum stress, inflammation, and oxidative stress. Front Cell Neurosci (2014) 1.53

Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS). Genes Dev (2011) 1.52

Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-κB activation and autoinflammatory disease. Proc Natl Acad Sci U S A (2016) 1.41

LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm (2013) 1.35

The tumor-immune microenvironment and response to radiation therapy. J Mammary Gland Biol Neoplasia (2010) 1.33

Constitutive intestinal NF-κB does not trigger destructive inflammation unless accompanied by MAPK activation. J Exp Med (2011) 1.33

Cyclooxygenase-2 and the inflammogenesis of breast cancer. World J Clin Oncol (2014) 1.15

The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants. Shock (2013) 1.12

BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer's disease. Mol Neurodegener (2012) 1.11

Novel anti-inflammatory activity of epoxyazadiradione against macrophage migration inhibitory factor: inhibition of tautomerase and proinflammatory activities of macrophage migration inhibitory factor. J Biol Chem (2012) 1.09

Poxvirus targeting of E3 ligase β-TrCP by molecular mimicry: a mechanism to inhibit NF-κB activation and promote immune evasion and virulence. PLoS Pathog (2013) 1.08

Sun Exposure and Its Effects on Human Health: Mechanisms through Which Sun Exposure Could Reduce the Risk of Developing Obesity and Cardiometabolic Dysfunction. Int J Environ Res Public Health (2016) 1.06

Exploitation of host cell biology and evasion of immunity by francisella tularensis. Front Microbiol (2011) 1.05

Cytokines as biomarkers of nanoparticle immunotoxicity. Chem Soc Rev (2013) 1.05

The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation. EMBO J (2013) 0.99

Novel Molecular Insights into Classical and Alternative Activation States of Microglia as Revealed by Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC)-based Proteomics. Mol Cell Proteomics (2015) 0.99

Delphinidin inhibits IL-1β-induced activation of NF-κB by modulating the phosphorylation of IRAK-1(Ser376) in human articular chondrocytes. Rheumatology (Oxford) (2013) 0.97

Paricalcitol attenuates 4-hydroxy-2-hexenal-induced inflammation and epithelial-mesenchymal transition in human renal proximal tubular epithelial cells. PLoS One (2013) 0.96

FOXO1 increases CCL20 to promote NF-κB-dependent lymphocyte chemotaxis. Mol Endocrinol (2012) 0.96

Anti-inflammatory cytokines: important immunoregulatory factors contributing to chemotherapy-induced gastrointestinal mucositis. Chemother Res Pract (2012) 0.95

Exposure to Radiocontrast Agents Induces Pancreatic Inflammation by Activation of Nuclear Factor-κB, Calcium Signaling, and Calcineurin. Gastroenterology (2015) 0.95

A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling. PLoS One (2012) 0.94

Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer. Br J Cancer (2013) 0.93

Deacetylation by SIRT1 Reprograms Inflammation and Cancer. Genes Cancer (2013) 0.92

Functional significance of macrophage-derived exosomes in inflammation and pain. Pain (2014) 0.92

Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism. J Inflamm (Lond) (2014) 0.92

Colony stimulating factor-1 receptor signaling networks inhibit mouse macrophage inflammatory responses by induction of microRNA-21. Blood (2015) 0.91

The complexity of the Nrf2 pathway: beyond the antioxidant response. J Nutr Biochem (2015) 0.91

Nucleated red blood cells impact DNA methylation and expression analyses of cord blood hematopoietic cells. Clin Epigenetics (2015) 0.90

α5β1 integrin signaling mediates oxidized low-density lipoprotein-induced inflammation and early atherosclerosis. Arterioscler Thromb Vasc Biol (2014) 0.90

Inhibition of multiple pathogenic pathways by histone deacetylase inhibitor SAHA in a corneal alkali-burn injury model. Mol Pharm (2012) 0.90

Harmine activates intrinsic and extrinsic pathways of apoptosis in B16F-10 melanoma. Chin Med (2011) 0.90

Plasmodium falciparum Histidine-Rich Protein II Compromises Brain Endothelial Barriers and May Promote Cerebral Malaria Pathogenesis. MBio (2016) 0.89

NFκB function and regulation in cutaneous T-cell lymphoma. Am J Cancer Res (2013) 0.89

NF-κB1 inhibits c-Myc protein degradation through suppression of FBW7 expression. Oncotarget (2014) 0.89

Ehrlichia chaffeensis induces monocyte inflammatory responses through MyD88, ERK, and NF-κB but not through TRIF, interleukin-1 receptor 1 (IL-1R1)/IL-18R1, or toll-like receptors. Infect Immun (2011) 0.89

Mitochondria and reactive oxygen species: physiology and pathophysiology. Int J Mol Sci (2013) 0.89

MTA1 coregulation of transglutaminase 2 expression and function during inflammatory response. J Biol Chem (2010) 0.89

The Herbal Drug Melampyrum pratense L. (Koch): Isolation and Identification of Its Bioactive Compounds Targeting Mediators of Inflammation. Evid Based Complement Alternat Med (2013) 0.88

Salvianolic Acid B, a potential chemopreventive agent, for head and neck squamous cell cancer. J Oncol (2010) 0.88

EGCG prevents PCB-126-induced endothelial cell inflammation via epigenetic modifications of NF-κB target genes in human endothelial cells. J Nutr Biochem (2015) 0.88

Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models. Blood (2014) 0.86

Inflammation, Cancer and Oxidative Lipoxygenase Activity are Intimately Linked. Cancers (Basel) (2014) 0.86

Cerebral nitric oxide represses choroid plexus NFκB-dependent gateway activity for leukocyte trafficking. EMBO J (2015) 0.86

Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammation. Curr Opin Chem Biol (2016) 0.85

Anthocyanin-rich fractions from red raspberries attenuate inflammation in both RAW264.7 macrophages and a mouse model of colitis. Sci Rep (2014) 0.85

PLTP regulates STAT3 and NFκB in differentiated THP1 cells and human monocyte-derived macrophages. Biochim Biophys Acta (2011) 0.85

A purified capsular polysaccharide markedly inhibits inflammatory response during endotoxic shock. Infect Immun (2012) 0.85

Molecular basis for defining the pineal gland and pinealocytes as targets for tumor necrosis factor. Front Endocrinol (Lausanne) (2011) 0.85

Targeting the redox balance in inflammatory skin conditions. Int J Mol Sci (2013) 0.84

Spinal mitochondrial-derived peroxynitrite enhances neuroimmune activation during morphine hyperalgesia and antinociceptive tolerance. Pain (2013) 0.84

Lung-derived mediators induce cytokine production in downstream organs via an NF-κB-dependent mechanism. Mediators Inflamm (2013) 0.84

Mineralocorticoid Receptors in the Pathophysiology of Vascular Inflammation and Atherosclerosis. Front Endocrinol (Lausanne) (2015) 0.84

The Role of Autophagy in Kidney Inflammatory Injury via the NF-κB Route Induced by LPS. Int J Med Sci (2015) 0.83

High density lipoproteins improve insulin sensitivity in high-fat diet-fed mice by suppressing hepatic inflammation. J Lipid Res (2013) 0.83

Identification of novel mechanisms involved in generating localized vulvodynia pain. Am J Obstet Gynecol (2015) 0.83

Next generation treatment of acute graft-versus-host disease. Leukemia (2014) 0.83

BTB-ZF transcriptional regulator PLZF modifies chromatin to restrain inflammatory signaling programs. Proc Natl Acad Sci U S A (2015) 0.83

Mitochondrial lysates induce inflammation and Alzheimer's disease-relevant changes in microglial and neuronal cells. J Alzheimers Dis (2015) 0.83

Activation of the c-Met Pathway Mobilizes an Inflammatory Network in the Brain Microenvironment to Promote Brain Metastasis of Breast Cancer. Cancer Res (2016) 0.83

Identification of genes and gene pathways associated with major depressive disorder by integrative brain analysis of rat and human prefrontal cortex transcriptomes. Transl Psychiatry (2015) 0.82

Complement protein C1q promotes macrophage anti-inflammatory M2-like polarization during the clearance of atherogenic lipoproteins. Inflamm Res (2014) 0.82

Regulation of (pro)renin receptor expression in mIMCD via the GSK-3β-NFAT5-SIRT-1 signaling pathway. Am J Physiol Renal Physiol (2014) 0.82

The RNA-binding protein TTP is a global post-transcriptional regulator of feedback control in inflammation. Nucleic Acids Res (2016) 0.82

Osmotin attenuates LPS-induced neuroinflammation and memory impairments via the TLR4/NFκB signaling pathway. Sci Rep (2016) 0.82

Methionine sulfoxide reductase A negatively controls microglia-mediated neuroinflammation via inhibiting ROS/MAPKs/NF-κB signaling pathways through a catalytic antioxidant function. Antioxid Redox Signal (2015) 0.81

Metformin represses cancer cells via alternate pathways in N-cadherin expressing vs. N-cadherin deficient cells. Oncotarget (2015) 0.81

Erucin exerts anti-inflammatory properties in murine macrophages and mouse skin: possible mediation through the inhibition of NFκB signaling. Int J Mol Sci (2013) 0.81

Hypoxia induces connexin 43 dysregulation by modulating matrix metalloproteinases via MAPK signaling. Mol Cell Biochem (2013) 0.81

Therapeutic potential of the proteasome inhibitor Bortezomib on titanium particle-induced inflammation in a murine model. Inflammation (2012) 0.81

Lipopolysaccharide modulates neutrophil recruitment and macrophage polarization on lymphatic vessels and impairs lymphatic function in rat mesentery. Am J Physiol Heart Circ Physiol (2015) 0.81

How the venom from the ectoparasitoid Wasp nasonia vitripennis exhibits anti-inflammatory properties on mammalian cell lines. PLoS One (2014) 0.81

Proinflammatory TLR signalling is regulated by a TRAF2-dependent proteolysis mechanism in macrophages. Nat Commun (2015) 0.81

Fatty acid synthase inhibitor C75 ameliorates experimental colitis. Mol Med (2014) 0.81

Interactions of Hepatitis B Virus Infection with Nonalcoholic Fatty Liver Disease: Possible Mechanisms and Clinical Impact. Dig Dis Sci (2015) 0.81

The Nogo/Nogo Receptor (NgR) Signal Is Involved in Neuroinflammation through the Regulation of Microglial Inflammatory Activation. J Biol Chem (2015) 0.80

Molecular Interactions between NR4A Orphan Nuclear Receptors and NF-κB Are Required for Appropriate Inflammatory Responses and Immune Cell Homeostasis. Biomolecules (2015) 0.80

Amelioration of experimental autoimmune uveoretinitis by aldose reductase inhibition in Lewis rats. Invest Ophthalmol Vis Sci (2011) 0.80

Mitochondrial dysfunction and oxidative stress in aging and cancer. Oncotarget (2016) 0.80

The conspiracy of autophagy, stress and inflammation in acute pancreatitis. Curr Opin Gastroenterol (2014) 0.80

Trefoil factor 1 expression suppresses Helicobacter pylori-induced inflammation in gastric carcinogenesis. Cancer (2015) 0.80

A Cytokine Signalling Network for the Regulation of Inducible Nitric Oxide Synthase Expression in Rheumatoid Arthritis. PLoS One (2016) 0.80

Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer. PLoS One (2016) 0.80

Evaluation of cytotoxicity, immune compatibility and antibacterial activity of biogenic silver nanoparticles. Med Microbiol Immunol (2016) 0.80

Downregulation of COMMD1 by miR-205 promotes a positive feedback loop for amplifying inflammatory- and stemness-associated properties of cancer cells. Cell Death Differ (2015) 0.80

Phytosphingosine derivatives ameliorate skin inflammation by inhibiting NF-κB and JAK/STAT signaling in keratinocytes and mice. J Invest Dermatol (2013) 0.80

Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway. Sci Rep (2016) 0.80

Diabetes alters vascular mechanotransduction data: Pressure-induced regulation of Nf-kapa-B p65 and translational associated signaling in the rat inferior vena cava. Data Brief (2017) 0.80

Qishen granules inhibit myocardial inflammation injury through regulating arachidonic acid metabolism. Sci Rep (2016) 0.80

Alpha-lipoic acid exerts anti-inflammatory effects on lipopolysaccharide-stimulated rat mesangial cells via inhibition of nuclear factor kappa B (NF-κB) signaling pathway. Inflammation (2015) 0.79

Transcriptomic and epigenetic analyses reveal a gender difference in aging-associated inflammation: the Vitality 90+ study. Age (Dordr) (2015) 0.79

Redefining the transcriptional regulatory dynamics of classically and alternatively activated macrophages by deepCAGE transcriptomics. Nucleic Acids Res (2015) 0.79

PAFR activation of NF-κB p65 or p105 precursor dictates pro- and anti-inflammatory responses during TLR activation in murine macrophages. Sci Rep (2016) 0.79

Hepatocyte growth factor preferentially activates the anti-inflammatory arm of NF-κB signaling to induce A20 and protect renal proximal tubular epithelial cells from inflammation. J Cell Physiol (2012) 0.79

HMGB1/RAGE induces IL-17 expression to exaggerate inflammation in peripheral blood cells of hepatitis B patients. J Transl Med (2015) 0.79

The Extracellular IFI16 Protein Propagates Inflammation in Endothelial Cells Via p38 MAPK and NF-κB p65 Activation. J Interferon Cytokine Res (2015) 0.79

Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation. J Cancer (2015) 0.79

An ethyl acetate fraction derived from Houttuynia cordata extract inhibits the production of inflammatory markers by suppressing NF-кB and MAPK activation in lipopolysaccharide-stimulated RAW 264.7 macrophages. BMC Complement Altern Med (2014) 0.79

Heat stress-induced memory impairment is associated with neuroinflammation in mice. J Neuroinflammation (2015) 0.79

Articles cited by this

Pathogen recognition and innate immunity. Cell (2006) 44.14

Cancer-related inflammation. Nature (2008) 34.21

Alternative activation of macrophages. Nat Rev Immunol (2003) 27.53

Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 24.36

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol (2000) 20.70

Missing pieces in the NF-kappaB puzzle. Cell (2002) 17.83

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science (1996) 13.87

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science (1998) 11.70

Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med (1995) 10.91

The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol (2004) 10.85

NF-kappaB: a key role in inflammatory diseases. J Clin Invest (2001) 9.66

The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell (1997) 8.74

Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science (2001) 7.66

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature (1995) 7.52

Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature (2007) 7.17

The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov (2004) 6.21

Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science (1999) 6.20

Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell (2006) 5.97

The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity (2002) 5.38

Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family. Cell (1995) 4.70

Inducible gene targeting in mice using the Cre/lox system. Methods (1998) 4.61

NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell (2007) 4.56

"Re-educating" tumor-associated macrophages by targeting NF-kappaB. J Exp Med (2008) 4.38

IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature (2005) 4.31

Inhibition of Stat1-mediated gene activation by PIAS1. Proc Natl Acad Sci U S A (1998) 4.12

Expression of relB is required for the development of thymic medulla and dendritic cells. Nature (1995) 3.99

The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med (2003) 3.85

Possible new role for NF-kappaB in the resolution of inflammation. Nat Med (2001) 3.53

Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. EMBO J (2004) 3.32

IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell (2001) 3.10

Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells. Immunity (2005) 2.97

Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J Exp Med (1998) 2.80

Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J Exp Med (1998) 2.78

p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res (2006) 2.76

NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes. Science (1992) 2.69

Modulation of NF-kappaB activity by exchange of dimers. Mol Cell (2003) 2.62

NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci U S A (1998) 2.61

Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis--CREB and NF-kappaB as key regulators. Immunity (2005) 2.56

RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells. Immunity (1998) 2.42

Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. Immunity (2006) 2.33

The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis. J Exp Med (2003) 2.20

Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment. J Immunol (2001) 2.16

Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I. J Exp Med (2001) 2.07

A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J Exp Med (1984) 2.06

A prominent role for airway epithelial NF-kappa B activation in lipopolysaccharide-induced airway inflammation. J Immunol (2003) 1.99

Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. Proc Natl Acad Sci U S A (2004) 1.95

Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J Immunol (2001) 1.95

Opposing functions of IKKbeta during acute and chronic intestinal inflammation. Proc Natl Acad Sci U S A (2008) 1.90

Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. J Clin Invest (1998) 1.89

Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity. Cell (2007) 1.89

Allergen-induced peribronchial fibrosis and mucus production mediated by IkappaB kinase beta-dependent genes in airway epithelium. Proc Natl Acad Sci U S A (2005) 1.87

An antiinflammatory role for IKKbeta through the inhibition of "classical" macrophage activation. J Exp Med (2008) 1.77

IkappaB kinase alpha is essential for mature B cell development and function. J Exp Med (2001) 1.76

IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis. Immunity (2001) 1.73

NF-kappa B activation in airways modulates allergic inflammation but not hyperresponsiveness. J Immunol (2004) 1.73

Induction of RelB participates in endotoxin tolerance. J Immunol (2006) 1.71

Rapid activation of nuclear factor-kappaB in airway epithelium in a murine model of allergic airway inflammation. Am J Pathol (2002) 1.66

Chronic inflammation: a failure of resolution? Int J Exp Pathol (2007) 1.54

Typhlocolitis in NF-kappa B-deficient mice. J Immunol (2001) 1.53

RelB regulation of chemokine expression modulates local inflammation. Am J Pathol (1997) 1.50

RelA repression of RelB activity induces selective gene activation downstream of TNF receptors. Proc Natl Acad Sci U S A (2005) 1.45

An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis. J Exp Med (1999) 1.44

Enhanced NF-kappaB activation and cellular function in macrophages lacking IkappaB kinase 1 (IKK1). Proc Natl Acad Sci U S A (2005) 1.41

A role for NF-kappa B subunits p50 and p65 in the inhibition of lipopolysaccharide-induced shock. J Immunol (2004) 1.41

Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB. J Biol Chem (1999) 1.39

NF-kappa B regulation by I kappa B kinase in primary fibroblast-like synoviocytes. J Immunol (1999) 1.36

Thymic cortical epithelium is sufficient for the development of mature T cells in relB-deficient mice. J Immunol (1997) 1.33

NF-kappa B regulation by I kappa B kinase-2 in rheumatoid arthritis synoviocytes. J Immunol (2001) 1.28

RelB modulation of IkappaBalpha stability as a mechanism of transcription suppression of interleukin-1alpha (IL-1alpha), IL-1beta, and tumor necrosis factor alpha in fibroblasts. Mol Cell Biol (1999) 1.28

Control of specificity and magnitude of NF-kappa B and STAT1-mediated gene activation through PIASy and PIAS1 cooperation. Proc Natl Acad Sci U S A (2007) 1.28

NF-kappaB1 (p50) is upregulated in lipopolysaccharide tolerance and can block tumor necrosis factor gene expression. Infect Immun (1999) 1.27

Cytokines as targets in chronic obstructive pulmonary disease. Curr Drug Targets (2006) 1.19

Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases. Curr Opin Pharmacol (2007) 1.17

NF-kappaB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type. Cell Death Differ (1999) 1.15

NF-kappa B is required within the innate immune system to inhibit microflora-induced colitis and expression of IL-12 p40. J Immunol (2003) 1.12

Cutting edge: NF-kappa B2 is a negative regulator of dendritic cell function. J Immunol (2004) 1.09

Zebrafish IkappaB kinase 1 negatively regulates NF-kappaB activity. Curr Biol (2005) 1.08

Inhibition of Helicobacter hepaticus-induced colitis by IL-10 requires the p50/p105 subunit of NF-kappa B. J Immunol (2006) 1.06

IKKalpha in the regulation of inflammation and adaptive immunity. Biochem Soc Trans (2007) 0.96

Cytokine and anti-cytokine therapy for the treatment of asthma and allergic disease. Cytokine (2004) 0.91

Apoptosis-resistant T cells have a deficiency in NF-kappaB-mediated induction of Fas ligand transcription. Eur J Immunol (1999) 0.80

Articles by these authors

Macrophages and NF-κB in cancer. Curr Top Microbiol Immunol (2011) 0.78